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High-frequency oscillatory
ventilation - rescue
treatment for infants with
severe respiratory failure
Johan Smith, Clarissa H Pieper, Gert F Kirsten,
David Maree, Jeanette van Zyl,
Marie-Louise Pretorius
Objective. To assess the efficacy of high-frequency
oscillatory ventilation (HFOV) as a rescue mode of therapy
in newborn infants with severe respiratory failure poorty
responsive or unresponsive to conventional ventilation and
supportive management.
Design. Prospective, descriptive clinical study.
Setting. Tertiary care neonatal intensive care unit.
Patients and methods. All infants WITh radiographic
evidence of diffuse bilateral lung disease and failure to
maintain adequate blood gas values while receiving
conventional support were offered HFOV.
Intervention. HFOV. utilising a high-pressure/volume
strategy.
Outcome variables. Improvement in arteriaValveolar
oxygen tension ratio (alAPOJ of the infants subsequent to
their transferral to HFOV; survival rate; and outcome of
infants weighing more than 2 000 9 who met criteria for
extracorporeal membrane oxygenation (ECMO). Identifying
the infants who met ECMO entry criteria allowed the
success of HFOV to be compared with that of ECMO, the
'standard' treatment for infants considered unventilatable.
Neonatal complications such as bronchopulmoocuy
dysplasia, intraventricular haemorrhage and air leaks were
documented.
Results. Conventional support failed in 34 consecutive
infants; they were transferred to HFOV at a mean postnatal
age of 30 hours. Their respiratory diagnoses included
respiratory distress syndrome (RDS) (N = 19), neonatal
'adult respiratory distress syndrome' (ARDS) (N = 3) and
meconium aspiration syndrome (MAS) (N = 12). Owing to
similarities in the underlying pathophysiology. ADS and
AADS were grouped together for the purposes of analysis.
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After starting HFOV the aJAPO, had significantly
improved (P < 0.05) by 6 hours in the RDS group and by
12 hours in the infants with MAS. This improvement was
sustained throughout the first 48 hours of HFOV. Twenty-
six (76%) of the infants ultimately survived. Among those
who met the criteria for ECMO (N = 13), the survival rate
was 92%. Air leaks occurred on HFOV in 6 infants. 3 each
in the MAS and RDS groups. Bronchopulmonary dysplasia
was diagnosed in 6 (40%) of the 15 RDS infants and in 2
(18%) of the 11 infants with MAS. Eight infants died, 3
following nosocomial sepsis (Pseudomonas sp.), 3 due to
extensive air leaks, 1 due to irreversible shock (unproven
sepsis), and 1 due to ARDS.
At a median age of 13.5 months the neurological
development of 11 (5%) of 17 infants was nonnal; in 3
(18%) it was suspect and in 3 abnormal.
Conclusions. The study demonstrates that a high-
pressure/volume approach to HFOV is an effective mode
of rescue ventilation for .infants who present with severe
respiratory failure caused by a variety of lung conditions
during the neonatal period.
S Ai, Med J 1998; 88: 484-489.
Mortality and respiratory morbidity from respiratory distress
syndrome (RDS) and meconium aspiration syndrome (MAS)
in neonates remain relatively high, despite the availability of
assisted ventilation and surfactant replacement therapy.Hi
According to a report by the South African Department of
Health, RDS was responsible for 10% of deaths in the age
group 0 - 4 years during 1992.' Adhikari and Gouws'
showed that the incidence of meconium aspiration varies
from 4 to 11/1 000 between institutions in South Africa. The
mortality rate among infants with MAS who required
intensive care and conventional ventilation was 36%.
High-frequency oscillatory ventilation (HFOV) has
previously been shown to improve survival rates in some
infants with RDS, MAS, neonatal 'adult respiratory distress
syndrome' (ARDS), lung hypoplasia syndromes and air
leaks, who failed to respond to conventional ventilation (CV)
and supportive management.6-1l Infants with congenital
diaphragmatic hernia and certain categories of MAS,
however, do not always respond favourably to ventilation
with high-frequency oscillators." There is therefore a need
to define the most appropriate indication(s) for HFOV,
especially in units with restricted physical resources and a
limited number of high-frequency oscillators.
The aim of this stUdy was to assess the efficacy of HFOV
as rescue treatment for infants with diffuse lung disease who
suffered from severe respiratory failure and in whom
conventional mechanical ventilation and supportive
management failed.
Patients
Consecutive infants with severe respiratory failure in whom
conventional ventilatory support failed to achieve adequate
oxygenation and/or who did not respond to bovine
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surfactant replacement therapy (SRI) and other supportive
medical management were transferred to HFOV.
All the infants had bilateral lung disease and fulfilled one
or more of the following criteria at the time of initiation of the
trial: ~) post-surfactant arteriaVatveolar oxygen tension ratio
(a/APO,) below 0.25 (N = 21); QI) partial carbon dioxide
tension (PaCO,) above 8 kPa (60 mmHg) despite ventilator
positive inspiratory pressure (PIP) in excess of 27 cm H,O
(N = 2); UiI) pulmonary interstitial emphysema and/or
pneumothoraces (N = 2); (iv) partial arterial oxygen tension
(PaO,) below 6.7 kPa (50 mmHg) despite a fractional
inspiratory oxygen concentration (FiO,) of 1.0 and PIP above
30 cm Hp (N = 7); and (v) persistent pulmonary
hypertension of the neonate (PPHN) associated with lung
disease (N = 11). Infants who had congenital diaphragmatic
hernia, asphyxia-related multi-organ failure wrth hypoxic
encephalopathy, lethal congenital malformations, or
'asymmetrical' lung disease such as focal MAS, unilateral
lung atelectasis or unilateral pulmonary interstitial
emphysema (PIE) were prospectively excluded from the
stUdy. This was done because experience from Wilford Hall
(San Antonio, Texas) with more than 400 infants has shown
that infants with homogeneous lung disease respond better
to HFOV than those with focal or unilateral involvement.'
Conventional ventilation was supplied by pressure-limited,
time-cycled neonatal ventilators (Sechrist, Anaheim, Calif. or
Healthdyne, Marietta, Ga.) using acceptable strategies to
achieve optimal alveolar recruitment, alveolar ventilation and
oxygenation.1Q Medical management included: ~) SAT in
cases of RDS or MAS in which the alAPO: remained 0.22 or
below within 5 hours of admission; (iI) circulatory support
(optimising preload and using inotropic support); and (jil)
alkali infusion and intravenous tolazoline therapy in cases of
PPHN.11 The infants were sedated with a continuous infusion
of midazolam. Babies weighing more than 2 000 g also
received pancuronium. HFOV was provided by a
SensorMedics 31 OOA oscillator.
Upon transfer to HFOV a high mean airway pressure
(MAP), high-volume strategy was followed for infants with
diffuse homogeneous alveolar disease (white-out). The MAP
setting on the oscillator was equal to the calculated MAP on
conventional ventilation plus 2 - 4 cm ~O. In cases of
pulmonary air leaks a MAP equal to the MAP on CV was
used. A frequency of 10Hz was used for infants weighing
less than 2 000 g and 8 - 10Hz for those weighing over
2 000 g. The inspiratory time (Ti) was kept at 33%. Pressure
amplitude was adjusted according to visible chest wall
excursions, transcutaneous PaCO: and measured arterial
PaCO,. During HFOV the settings were constantly adjusted
to maintain the PaO: PaCO: and pH within the desired
range. IQ Inspired gas temperature was kept at 36°C. Once
optimal lung volume was obtained, the RO: was reduced in
a stepwise fashion to below 0.30 in preference to lowering
the MAP. Optimal lung volume was defined as 8 to 9
posterior rib level expansion and decreased opacification or
haziness of both lung fields on the chest radiograph. With
the FiO: below 0.30, MAP reduction was given equal priority
in the weaning process. Oscillatory amplitude was weaned
according to PaCq, levels. Once low settings on HFOV were
reached or patchy atelectasis due to mucus occurred, the
infants were transferred to CV for further weaning and
extubation. A MAP below 8 - 10 cm H,O and oscillatory
ampiitude equal to or below 20 - 22 cm H,O in the presence
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of adequate blood gas levels while receiving a FiG, of 0.35
or less were considered 'Iow settings'.
Information on the infants' ventilatory progress was
obtained from their medical records. Infants served as their
own controls. The a1APO: was determined before and after
switch-Qver to HFOV and thereafter at 6 - 12-hourly intervals
up to 48 hours of HFOV. The oxygenation index (01) was
calculated before changing to HFOV.I% The 01 is a
measurement of the amount of inspired oxygen and driving
pressure required to oxygenate the arterial bk>od. A higher
01 indicates a more severe oxygenation deficit. For infants
weighing over 2 000 g (> 34 weeks' gestation) the 01 was
used to determine the need for ECMO. An 01 of 30 or above
for more than 4 hours before changing to HFOV has
previously been shown to carry a mortality risk of 70% or
more.13 In addition to weight, gestational age and 01, the
following setection criteria were used to determine ECMO
candidates: acute deterioration (either PaO: < 50 mmHg
(6.7 kPa) or pH < 7.15 for 2 hours), unresponsiveness (two
of the following for more than 3 hours - PaO: < 50 mmHg
(5.7 kPa) on FiO: 1.0; pH < 7.27; evidence of barotrauma
(interstitial emphysema, pneumothorax». Meconium
aspiration syndrome was diagnosed in infants who had
bilateral patchy infiltrates or diffuse lung opacification on the
chest radiography together with a history of both
meconium-stained liquor and meconium aspiration at birth.
Bronchopulmonary dysplasia (BPD) was defined as
dependence on oxygen beyond 28 days with a chest
radiograph showing persistent changes. 1• NeonataJ 'ARDS'
was respiratory distress necessitating ventilation with
positive end-expiratory pressure (PEEP) exceeding 5 cm H20
in a near-term or term infant who had echocardiographically
documented PPHN and a chest radiograph with dense,
bilateral alveolar opacffication.l $
Where possible infants were followed up after discharge
and their motor developmental outcome assessed according
to the method of Tison.!6 Motor development was classified
as normal. suspect or abnormal. Suspect development was
defined as abnormal muscle tone with normal reflexes, and
abnormal development as any form of cerebral palsy.
Statistical analysis was done on a personal computer
using the Stratgraphics programme. Basic descriptive
analysis as well as ANOVA methods and Student's Hest
were used.
Results
Between May 1992 and November 1994, 34 infants with
RDS (N = 19), neonatal ARDS (N = 3) and MAS (IV = 12)
received a trial of HFOV. Owing to similarities in their disease
profiles, the infants with RDS and ARDS were grouped and
anatysed together. The clinical characteristics and ventilator
settings with calculated indices are summarised in Tables I
and 11.
Three patients (9%) initially failed to respond to HFOV
after 1, 5 and 31 hours respectively, and died. Their
diagnoses were severe air leak, AROS, and shock probably
related to sepsis. Of the remaining 31 infants, a further 5
died during the neonatal period. Three contracted
fulminating nosocomially acquired Pseudomonas
septicaemia and 2 developed extensive air leaks. Twenty-six
infants (76%) survived to discharge. Two (18%) of the 11
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Table 11. Ventilator settings and calculated indices 1 - 3 hours
before transferring the infants to HFOV (median and range)
Table I. Clinical characteristics of the 34 infants studied (median
and range)
infants with MAS and 6 (40%) of the 15 with ADS who
survived developed BPO. The outcome in the various patient
groups is shown in Table Ill.
0.35
0.30 OROS
HFOV ~.~ " .O~ ,0
...~ 0.25 ~* ~ ~
'"
Cf
0 0.20 I.
C- I
~ I0.15 .I
--0-_ I
Fig. 1. Mean alAP0
2
for each treatment group over the first 48
hours after initiating HFOY. Analysis of variance for repeated
measures indicated significant intragroup differences in aJAPO
between 0 and 6 hours (P < 0.05) and 0 and 12 hours after HFOV.
for RDS and MAS, respectively. No intergroup differences were
noted.
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ADS
(N = 22)
1487
(720 - 3 2(0)
32 (27 - 40)
13/9
17/5
5 (23%)
20 (91%)
1 (1 - 3)
4 (18%)
18 (3 - 216)
MAS
(N = 12)
3165
(2 460 - 3 900)
40 (34 - 43)
517
6/6
6 (50%t
3 (25%)
1
9 (75%)
14(1-65)
Gestational age (wks)
Gender (MIF)
Inbomloutborn
Apgar < 6 at 5 min
Surfactant before HFOV
Surfactant doses before HFQV
PPHN
Age at HFOV (h)
• P: 0.03, MAS v. ADS.
Birth weight (g)
Twenty of the 22 infants with ADS (91 %) received and
failed to respond to at least one dose of bovine surfactant.
Their mean a/APO: ratio did not improve from pre-SRT
levels to the pre-HFOV level (0.09 v. 0.12; P = NS). The 3
infants with MAS who received SAT also experienced no
improvement in alAP02 ratio before switch-over to HFOV.
By 6 hours, infants with ADS were more likely to have
responded to HFOV in terms of the alAP02 ratio than were
neonates with MAS for the same oscillator settings (MAP
18 cm H,O). Although both groups had a sustained
improvement over the first 48 hours, the MAS infants had a
lower response rate overall (P = NS) (Fig. 1). The median
duration of HFOV was 95 hours and 85 hours in the ADS
and MAS infants, respectively.
Thirteen infants met ECMO criteria. All of them had an 01
of 30 or above for 4 hours. In addition, 2 infants had
pneumothorax with pulmonary interstitial emphysema and 7
Table Ill. Outcome of patient groups
FiO,
PIP (cm HP)
MAP (cm HP)
PaO, (kPa)
PaCO, (\<pa)
01
Air leaks
IVH (all grades)
Atelectasis on HFOV
HFOV duration (h) (mean (SO))
BPD day 28
Survival
• Two Infants had air leak(s) before HFOV.
MAS
(N = 12)
1.0 (0.6 - 1.0)
30 (25 - 50)
12.7 (7 - 22.5)
6.2 (2.7 - 8.8)
4.7 (3 - 5.3)
28 (10 - 65)
MAS
(N = 12)
3 (25%)
o
2 (18%)
65 (29)
2 (18%)
11 (92%)
RDS
(N=22)
1.0 (0.4 - 1.0)
30(15-47)
12.6 (5 - 20)
8.9 (3.9 - 25.7)
6.1 (3.8-10)
14 (4.5 - 65)
RDS
(N = 22)
5 (23%t
3 (14%)
2 (13%)
95 (42)
6 (40%)
15 (6B%)
experienced acute deterioration in respiratory status. Twelve
(92.3%) of them responded favourably to HFOV and
survrved.
"Jr leaks developed during HFOV in 25% of the infants
with MAS compared with 13.6% of those with ADS (P =
NS). Intraventricular haemorrhage (IVH) occuned in 3 (14%)
of the infants with ADS (Table Ill). Omitting those infants who
weighed more than 2 000 g increased the incidence of IVH
to 21%.
Five infants developed post-extubation stridor, 2 multiple
suboccipital subcutaneous abscesses and 1 laryngeal
ulceration. One of the infants who developed stridor required
a tracheostomy for subglottic stenosis. Atelectasis dUring
HFOV occuned more frequently in the right upper lobe (3 of
4 infants) and was the main reason for switch-over to CV
during weaning Qn 15% of the cohort).
Autopsies were performed on 5 of the 8 infants who died.
Major findings included necrotising tracheobronchitis
(N = 1), diffuse alveolar damage with air leaks (N ~ 2),
bronchopneumonia (N = 1) and pulmonary haemorrhage
(N = 1).
Seventeen (65%) of 26 survivors were seen at follow-up.
Neuromotor development was assessed at the median
corrected postnatal age of 13.5 months (range 3 - 26
months). Development was considered normal in 11 children
(65%), as suspect in 3 (18%), and as abnormal in 3 (1
spastic quadriplegia, 2 spastic diplegia). One child had
severe bilateral sensorineural deafness. Two of the children
who were categorised as developmentaJly abnormal had had
severe birth asphyxia and a birth weight below 1 600 g.
Discussion
This study confirms the efficacy of HFOV in infants with
severe bilateral diffuse lung disease who failed to improve
with conventional mechanical ventilation. The overall survrval
rate of 76.5% and nonnal neurodevelopmental outcome of
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65% are encouraging and suggest that HFOV should be
considered as an essential step in a staged approach to
rescue infants who fail to respond to conventional
mechanical ventilation and supportive management.
Extraordinary treatment modalities such as HFOV have
been shown to benefit a large number of infants suffering
from a variety of neonatal respiratory conditions.IVA17.l\1 The
goal of introducing HFOV in the treatment of severe lung
disease is to improve oxygenation/gas exchange at lower
risk of barotrauma and therefore lung morbidity and
mortality.l.l\1 Conflicting results of studies investigating HFOV
can be attributed to different devices utilised, different
oscillation and MAP strategies, and the heterogeneity of
underlying lung conditions of infants enrolled.
Homogeneous, diffuse alveolar opacification (ADS or group
B streptococcal pneumonia) or non-homogeneous lung
inVOlvement, either unilateral or patchy (MAS, air leaks),
results in varying response rates to HFO.6,\I.l8.l\1 Management
strategies for HFO under these diverse circumstances
therefore have to differ. Diffuse, homogeneous lung disease
on chest radiography was the presenting problem in the
majority of infants with RDS and MAS in our study.
Pathophysiologically this represents damaged, atelectatic
lungs which have to be re-expanded and then maintained
above their closing pressure.2O Since there is inconsistency
in the recommendations regarding the initial levels of MAP
to be employed on switch-over from CV to HFOV, we chose
the high-pressure/volume strategy. Our approach was
influenced by the disappointing results of the HIFI stUdy, T1
which showed no advantage of HFOV over CV in the
management of ADS when similar MAPs were used (a
low-pressure/volume approach),2O.21 and the favourable
results of studies in which high priority was given to achieve
early atveolar re-expansion by volume recruitment
manoeuvres.l ,20-:l3 Increasing MAP on transfer from CV to
HFOV resulted in significantly imprOVed oxygenation
(improVed a/APO, ratios) in both the RDS (after 6 hours) and
the MAS (after 12 hours) infants in the present study,
confirming the effectiveness of this approach. The slightly
poorer improvement in aIAP02 ratios observed in the MAS
infants could be attributed to underlying PPHN, blunting the
magnitude of the oxygenation response. The lastmentioned
finding supports the strategy that once adequate lung
volume has been achieved, other treatment modalities such
as nitric oxide should be considered to further decrease
pulmonary shunting and thereby improve oxygenation.
In contrast to a previous report, we did not observe
uniformly poor response of infants with MAS to HFOV.ll Our
success rate (92% survivaO with HFOV in this group of
patients may have been influenced by the prospective
sefection of infants with a more uniform appearance of MAS
on chest radiography. Although we empirically increased the
MAP by 2 - 4 cm H20 upon transferring infants from CV to
HFOV (in the absence of air leaks), the volume optimisation
strategy proposed by Chan et al. 24 provides a more realistic
approach to identification of the initial optimal MAP in
infants with ADS (stiff lungs). By increasing MAP in a
stepwise manner from 0 cm ~O to + 2 cm H20, and then to
+ 5 cm H20, they were able to determine the optimal
oxygenation response within 40 minutes.
From the results of our own study and those of others it
appears that HFOV is effective. even after lung injury is
established.11.l\1.25 As we have mentioned, there are
categories of infants with established disease who respond
more poorly to HFOV than others.1l18.l9 Specific conditions
include air leaks, III pulmonary hypoplasia syndromes,ll.18 and
subgroups of MAS with airway disease (gas trapping).ll
Recently Paranka et al. 11 showed that the presence of
congenital diaphragmatic hernia with lung hypoplasia
(CDHILH) or an a/APO, ratio below 0.05 among non-
CDHILH patients at the onset of HFOV and subsequent lack
of improvement after 6 hours of HFOV (a/APO, '" 0.08) were
independently predictive of failure to respond to HFOV.
Overall, in the present study the aJAP02 was a very poor
predictor of responsiveness to HFOV in babies of 34 weeks'
gestational age or more. An initial aJAP02 of less than 0.05
and a subsequent ratio of 0.08 predicted poor
responsiveness with a sensitivity of 10% and specfficity of
0%, and a sensitivity of 46% and specificity of 0% at the
onset of oscillation and after 6 hours, respectively.
The poor predictive power observed highlights the
influence of patient sefection. time elapsed before initiation
of HFOV, size of study populations and dependence of
variables on physician-directed changes to the ventilator.
Subjecting certain categories of critically ill infants to a too-
short trial of HFOV (Le. ~ 6 hours) to evaluate their response
might not be adequate. Before deciding to withdraw HFOV,
attention has to be focused on the underlying lung and
cardiac physiology. Meconium aspiration syndrome with
bilateral patchy or diffuse opacification and associated
PPHN might necessitate a more lengthy trial of HFOV before
withdrawal is considered. Concern has been raised
regarding the relationship of a high-MAP, high-volume
approach and raised intracranial pressure and an increased
risk of intracranial haemorrhage in premature infants.1121.2l1
There is evidence to support the view that HFOV induces
changes in intracranial compliance through affecting
cerebral blood volume and interstitial fluid volume as a
consequence of impaired venous return.21 Walker et al. 28
demonstrated in newborn lambs that intracranial compliance
and cerebral perfusion pressure at normal and elevated
airway pressure were similar during HFOV and CV. They
concluded that HFOV did not seem to be mechanically
disruptive to the newborn cerebral circulation. The 21 %
incidence of IVH among infants with ADS in the present
study was similar to that of comparable historical controls in
our unit,29 corroborating the findings of Walker et al.28
Necrotising tracheobronchitis (NTB) has been reported as
a complication related to mechanical ventilation in infants
with RDS::lO Although the exact causation is not known,
raising the mean airway pressure above 20 cm H20 in
anaesthetised adult rabbits undergoing HFOV resulted in a
significant drop in bronchial mucosal blood flow in the
presence of a constant cardiac output.31 The present study
documented NTB in 1 of 5 patients on whom autopsy was
performed. This patient was our index case and was
switched from CV to HFO at the postnatal age of 37 hours.
The potential contributory role of CV to the occurrence of
NTB in this case could therefore not be determined.
Several First-World countries now have a number of
neonatal units with both HFOV and ECMO available as the
final forms of intervention in near-term or term infants with
severe respiratory failure. It remains controversial whether
ECMO facilities should be available in developing
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countries.'1 HFOV, however, appears to be relativety free of
significant morbidity compared with ECMO, and should
therefore be considered as part of a staged intervention
strategy in the attempt to rescue severely ill infants with
RDS, neonatal ARDS and certain categories of MAS.
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